✦ LIBER ✦

DURABILITY OF RESPONSE: THE ACHILLES HEEL OF SALVAGE COMBINATION IMMUNOTHERAPY WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN AND INTERFERON-ALPHA 2B IN BLADDER CANCER

✍ Scribed by Prasad, Sandip M.; Eyre, Stephen J.; Loughlin, Kevin R.

Book ID: 122508579
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 124 KB
Volume: 181
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(09)60210-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of Lymphocytic Responses afte

Evaluation of Lymphocytic Responses after Treatment with Bacillus Calmette-Guerin and Interferon-α 2b for Superficial Bladder Cancer

✍ Yunn-Hwen Gan; Ratha Mahendran; Keith James; Carmel Lawrencia; Kesavan Esuvarana 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Safety and Efficacy of Intravesical Baci

Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Plus Interferon α-2b Therapy for Nonmuscle Invasive Bladder Cancer in Patients With Prosthetic Devices

✍ Rosevear, Henry M.; Lightfoot, Andrew J.; Nepple, Kenneth G.; O'Donnell, Michael 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 398 KB

Bacillus Calmette-Guérin Is Superior to

Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study

✍ Miloš Duchek; Robert Johansson; Staffan Jahnson; Oddvar Mestad; Pekka Hellström; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 447 KB

Usefulness of the Spanish Urological Clu

Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α

✍ Rosevear, Henry M.; Lightfoot, Andrew J.; Nepple, Kenneth G.; O'Donnell, Michael 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 128 KB

491 Evaluation of urine interleukin-2 (I

491 Evaluation of urine interleukin-2 (IL2), IL6 and IL10 levels during intravesical therapy with interferon α-2B (IFNα-2B) alone and IFINα-2B combined with low dose bacillus Calmette-Guérin (BCG) in superficial bladder cancer

✍ L. Özdal; T. Özdemir; K. Yakupoǧlu; S. Bulut; A. Memiş; O. Sariyüce 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 207 KB